PMID- 19021717 OWN - NLM STAT- MEDLINE DCOM- 20090616 LR - 20081121 IS - 1365-2362 (Electronic) IS - 0014-2972 (Linking) VI - 38 IP - 12 DP - 2008 Dec TI - Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction. PG - 925-30 LID - 10.1111/j.1365-2362.2008.02051.x [doi] AB - BACKGROUND: Microangioathy and macroangiopathy in type 2 diabetes mellitus (T2DM) frequently coexist. Both types of vascular complications share traditional risk factors. It is not clear whether the presence of microangiopathy, such as diabetic retinopathy (DR), constitutes a predictor of atherosclerosis in T2DM. Here we described the search for the association between DR and intima-media thickness (IMT) in T2DM. We also compared endothelial function in subjects with and without DR. MATERIAL AND METHODS: We examined 182 consecutive patients with T2DM for at least 5 years (mean age at examination 56.3 +/- 6.52 years). We assessed (i) IMT of carotid artery by ultrasound and (ii) endothelial function by flow-mediated dilatation (FMD) method as well as by measurement of concentrations of von Willebrand factor (vWF) and s-ICAM-1. All patients underwent ophthalmological examination. Statistical analysis included Student's, Mann-Whitney, chi-square, Fisher tests and multiple regression. RESULTS: DR was found in 71 (39.0%) subjects. IMT was higher in patients with DR than those without DR (0.87 mm vs. 0.79 mm, respectively, P = 0.0001). FMD was lower in the complication group than in subjects without DR (8.38% vs. 10.45%, respectively, P = 0.0023). Concentrations of s-ICAM-1 and vWF were not different between the groups. In multiple regression analysis, DR was among the predictors of increased IMT (P = 0.016) and decreased FMD (P = 0.002). We did not find a significant association of DR with vWF and s-ICAM-1 (P = 0.09 and P = 0.11, respectively). CONCLUSIONS: DR is associated with increased IMT and endothelial dysfunction in T2DM. Impaired endothelial function may be a common denominator of pathogenesis of microvascular complications and atherosclerosis in T2DM. FAU - Malecki, M T AU - Malecki MT AD - Department of Metabolic Diseases, Medical College, Jagiellonian University, Krakow, Poland. malecki_malecki@yahoo.com FAU - Osmenda, G AU - Osmenda G FAU - Walus-Miarka, M AU - Walus-Miarka M FAU - Skupien, J AU - Skupien J FAU - Cyganek, K AU - Cyganek K FAU - Mirkiewicz-Sieradzka, B AU - Mirkiewicz-Sieradzka B FAU - damek-Guzik, T A AU - damek-Guzik TA FAU - Guzik, T J AU - Guzik TJ FAU - Sieradzki, J AU - Sieradzki J LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Eur J Clin Invest JT - European journal of clinical investigation JID - 0245331 RN - 0 (von Willebrand Factor) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Atherosclerosis/*pathology MH - Carotid Arteries/*pathology MH - Diabetes Mellitus, Type 2/*pathology MH - Diabetic Angiopathies/*pathology MH - Diabetic Retinopathy/pathology MH - Endothelium, Vascular/pathology MH - Female MH - Humans MH - Male MH - Middle Aged MH - Regression Analysis MH - Risk Factors MH - Tunica Intima/*pathology MH - Tunica Media/*pathology MH - von Willebrand Factor/metabolism EDAT- 2008/11/22 09:00 MHDA- 2009/06/17 09:00 CRDT- 2008/11/22 09:00 PHST- 2008/11/22 09:00 [pubmed] PHST- 2009/06/17 09:00 [medline] PHST- 2008/11/22 09:00 [entrez] AID - ECI2051 [pii] AID - 10.1111/j.1365-2362.2008.02051.x [doi] PST - ppublish SO - Eur J Clin Invest. 2008 Dec;38(12):925-30. doi: 10.1111/j.1365-2362.2008.02051.x.